Vasan Ramachandran, MD, Helms Second Edition of the Encyclopedia of Cardiovascular Research and Medicine
In a major milestone for global health and cardiological research, Elsevier has officially announced the publication of the second edition of the . This highly anticipated reference work is spearheaded by Editor-in-Chief , dean of the at the University of Texas at San Antonio.
The first edition of the encyclopedia was among Elsevier’s most popular science encyclopedias, leading to the commissioning of this expanded second edition that captures the rapid, transformative advancements in cardiovascular science over recent years.
A Definitive Resource Edited by a Global Leader in Public Health
Ramachandran, a world-renowned cardiologist and epidemiologist, serves as the edition’s Editor-in-Chief. He previously served as the Principal Investigator of the legendary Framingham Heart Study (2014–2022) and currently leads the National Heart, Lung, and Blood Institute-funded (RURAL) Study, which investigates critical cardiovascular health disparities in the rural South, including Southern Appalachia and the Mississippi Delta. A recent intends to expand research in Texas in the near future.
Ramachandran’s research expertise, which spans non-medical determinants of health, genomic biomarkers of cardiovascular risk, and heart failure epidemiology, has directly shaped the comprehensive, multidisciplinary scope of this new edition.
What is the Encyclopedia of Cardiovascular Research and Medicine?
Now available in both four-volume print and digital formats, the Encyclopedia of Cardiovascular Research and Medicine (2e) is a curated reference work designed for students, clinicians, educators, and researchers.
The second edition features approximately 180 expert-authored articles covering the entire spectrum of cardiovascular science. The collection bridges the gap between different scientific disciplines, categorized into key areas including:
- Basic and Vascular Biology: Cardiac development, regeneration, and vascular mechanisms.
- Cutting-Edge Technology: Genetics, omics technologies, and advanced cardiovascular imaging.
- Clinical Cardiology: Heart failure, coronary and acute cardiac syndromes, electrophysiology, and device therapies.
- Public Health: Population health, modern research methodologies, and preventive medicine.
Why This Edition is More Significant Than Ever
Cardiovascular disease (CVD) remains the leading cause of death worldwide. As clinical practices evolve and genomic technologies advance, healthcare professionals require a centralized, authoritative source of truth to translate laboratory discoveries into life-saving clinical care.
The significance of this second edition lies in its holistic, "bench-to-bedside-to-population" approach. By combining basic laboratory science with clinical treatment models and population health strategies, the encyclopedia serves as an indispensable tool for combatting the global CVD epidemic. It equips the next generation of doctors and researchers with the insights needed to improve patient outcomes, understand social determinants of cardiovascular health, and implement effective preventative measures.
In announcing the publication, Elsevier and the editorial board expressed deep gratitude to the global medical community:
"A heartfelt thank you to all editors, authors, and everyone whose time, expertise, and collaboration made this edition possible. Your dedication to advancing the field of cardiology is greatly appreciated."
With Ramachandran at the helm, the Encyclopedia of Cardiovascular Research and Medicine (2nd Edition) stands as a testament to the power of collaborative science and represents a vital weapon in the ongoing fight against heart disease.
is now available online via ScienceDirect and in print through Elsevier.